ArchivesMagazine - 28 Jul 2016News in brief: Fevertree Drinks, Lakehouse, Gateley, Non-Standard Finance, ImmuPharma, Osirium Technologies 28 July 2016|News|by Contributor Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Director dealings: Top buys & sells A game of two halves > Issue: 28 Jul 2016 - Page 8 | Contents Next: A game of two halves Previous: Director dealings: Top buys & sells Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Contributor Issue Contents Chartist Trading blue chip risers Exchange-Traded Funds Keep track of the sector switch Feature The gold rally downside Diary: Standard Chartered A game of two halves Director dealings: Top buys & sells Cropper’s family magic Unlocking hidden Treasure An electric trio of UK stocks Is Hotel Chocolat any good? Best & Worst Performing Small Caps Table Crunch time for Sphere Medical Picking from ‘best buy’ fund lists Secrets of successful acquisitions Where next for euro/pound? The Best & Worst Performers: FTSE 350, Global Market, Commodities, Forex, Sovereign Yields News Seven days on our website Steer clear of Sainsbury’s Superglass deal likely a one-off EU sales, profits under pressure Activist demands Speedy Hire sacking Maiden profit eyed for CityFibre News in brief: Fevertree Drinks, Lakehouse, Gateley, Non-Standard Finance, ImmuPharma, Osirium Technologies Franchise Brands at your service Analysts balk at Intertek rating Personal Finance Innovative ISAs are a big ‘if’ Rebasing your expectations Plays Sophos has big potential UDG is on the prowl Plays update: Victrex Plays update: Petra Diamonds Trading Strategies Avoid a currency crunch
